EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Short‐Chain Fatty Acids: Microbial Metabolites Driving Gut‐Eye Axis Signaling

Aleah J Brokemond iD, Ronny Amamoo iD, Fapianey J Alexandre, Sewedo B Ajisegiri iD, Menaka C Thounaojam iD, Pamela M Martin iD, Ravirajsinh N Jadeja iD

Comprehensive Physiology · 2026-10 · 16 (5)

DOI: 10.1002/cph4.70251 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Comprehensive Physiology, online erschienen am 09.09.2026. Verfasst von Aleah J Brokemond und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, School of Graduate Studies Meharry Medical College Nashville Tennessee USA. Die Arbeit nennt 156 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, NIGMS NIH HHS, NEI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Short‐chain fatty acids (SCFAs) have emerged as key molecular mediators of gut–eye communication, linking microbial metabolism to ocular physiology and disease. Produced through microbial fermentation of dietary fiber, SCFAs function as systemic signaling molecules that regulate immune homeostasis, metabolic function, vascular integrity, and neuroinflammatory pathways through activation of SCFA‐responsive receptors and epigenetic mechanisms. Growing evidence indicates that SCFAs influence biological processes central to ocular health, including inflammation, oxidative stress, neurodegeneration, and pathological angiogenesis. Experimental, metabolomic, and emerging clinical studies suggest that disruptions in SCFA signaling may contribute to the pathogenesis of retinal and ocular surface diseases; however, the mechanisms governing ocular exposure, target engagement, and therapeutic efficacy remain incompletely understood, highlighting a critical gap between mechanistic insight and clinical translation. In this review, we integrate current evidence into a mechanistic and translational framework that positions SCFAs as central effectors of the gut–eye axis. We further evaluate the therapeutic potential of SCFA modulation and identify key barriers to clinical implementation, including bioavailability, pharmacokinetics, dosing, and long‐term safety, thereby delineating a roadmap for the development of microbiome‐derived precision therapeutics in ophthalmology.

Schlagwörter

Stichwörter der Autor:innen

butyrategut‐eye axismicrobiomeocular diseasesshort‐chain fatty acids

Autor:innen und Institutionen

  • Department of Biomedical Sciences, School of Graduate Studies Meharry Medical College Nashville Tennessee USA.

ORCID-Profile: Aleah J Brokemond, Ronny Amamoo, Sewedo B Ajisegiri, Menaka C Thounaojam, Pamela M Martin, Ravirajsinh N Jadeja

Förderung

  • NHLBI NIH HHS
  • NIGMS NIH HHS
  • NEI NIH HHS
  • NIAID NIH HHS
  • National Eye Institute
  • National Institute of General Medical Sciences
  • National Heart and Lung Institute
  • National Institute of Allergy and Infectious Diseases

Zitieren

APA

Brokemond, A. J., Amamoo, R., Alexandre, F. J., Ajisegiri, S. B., Thounaojam, M. C., Martin, P. M., & Jadeja, R. N. (2026). Short‐Chain Fatty Acids: Microbial Metabolites Driving Gut‐Eye Axis Signaling. Comprehensive Physiology, 16(5). https://doi.org/10.1002/cph4.70251

Vancouver

Brokemond AJ, Amamoo R, Alexandre FJ, Ajisegiri SB, Thounaojam MC, Martin PM, et al. Short‐Chain Fatty Acids: Microbial Metabolites Driving Gut‐Eye Axis Signaling. Comprehensive Physiology. 2026;16(5). doi:10.1002/cph4.70251

BibTeX
@article{Brokemond2026,
  author = {Brokemond, Aleah J and Amamoo, Ronny and Alexandre, Fapianey J and Ajisegiri, Sewedo B and Thounaojam, Menaka C and Martin, Pamela M and Jadeja, Ravirajsinh N},
  title = {Short‐Chain Fatty Acids: Microbial Metabolites Driving Gut‐Eye Axis Signaling},
  journal = {Comprehensive Physiology},
  year = {2026},
  volume = {16},
  number = {5},
  doi = {10.1002/cph4.70251}
}
Kostenlos starten →